{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:36:50Z","timestamp":1793140610535,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.radonc.2026.111516","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:07:37Z","timestamp":1775059657000},"page":"111516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I\u2013III small cell lung cancer"],"prefix":"10.1016","volume":"219","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-8899","authenticated-orcid":false,"given":"Antonin","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Le P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-1534","authenticated-orcid":false,"given":"Bj\u00f8rn","family":"Gr\u00f8nberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-3856","authenticated-orcid":false,"given":"Andreas","family":"Rimner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Y.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-6338","authenticated-orcid":false,"given":"Valeria","family":"Dionisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Menis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Reguart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2268-0492","authenticated-orcid":false,"given":"Coen","family":"Hurkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-4592","authenticated-orcid":false,"given":"Ben J.","family":"Slotman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-9781","authenticated-orcid":false,"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111516_b0005","doi-asserted-by":"crossref","unstructured":"Detterbeck FC, Woodard GA, Bader AS, Dacic S, Grant MJ, Park HS, Tanoue LT. The Proposed Ninth Edition TNM Classification of Lung Cancer. Chest. 2024;166:882-895.","DOI":"10.1016\/j.chest.2024.05.026"},{"key":"10.1016\/j.radonc.2026.111516_b0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"ESMO guidelines committee. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.radonc.2020.07.012","article-title":"ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer","volume":"152","author":"Le Pechoux","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: an ASTRO Clinical Practice Guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0025","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.20.03364","article-title":"Radiation therapy for small-cell lung cancer: ASCO guideline endorsement of an ASTRO guideline","volume":"39","author":"Daly","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0035","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1200\/JCO.22.01359","article-title":"High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)\/RTOG 0538","volume":"41","author":"Bogart","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(20)30742-7","article-title":"High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial","volume":"22","author":"Gr\u00f8nberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0045","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1470-2045(13)70511-4","volume":"15","author":"Kubota","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2018.02.023","article-title":"ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer","volume":"127","author":"Nestle","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2009.04.075","article-title":"Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study","volume":"77","author":"van Loon","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S2213-2600(24)00010-9","article-title":"Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial","volume":"12","author":"Steinfort","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.radonc.2026.111516_b0065","article-title":"Diagnosis and treatment of radiation-induced pneumonitis: ESTRO expert consensus and practical guidance","volume":"184","author":"De Ruysscher","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.canrad.2023.08.012","article-title":"A prospective observational study evaluating two patient immobilisation methods in lung stereotactic radiotherapy","volume":"28","author":"Boisbouvier","year":"2024","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2026.111516_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2006.05.024","article-title":"Design of 4D treatment planning target volumes","volume":"66","author":"Rietzel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.clon.2020.09.008","article-title":"Image-guided radiotherapy to manage respiratory motion: lung and liver","volume":"32","author":"Dhont","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2026.111516_b0085","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cncr.32586","article-title":"Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses","volume":"126","author":"Hu","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0090","unstructured":"International Commission on Radiation Units and Measurements. ICRU Report 62. Prescribing, recording, and reporting photon beam therapy (Supplement to ICRU Report 50). ICRU, Bethesda, MD, 1999."},{"key":"10.1016\/j.radonc.2026.111516_b0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.prro.2012.01.007","article-title":"Computed tomographic atlas for the new international lymph node map for lung cancer: a radiation oncologist perspective","volume":"3","author":"Lynch","year":"2013","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0100","first-page":"799","article-title":"Trial Management Group. High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial. Lancet","volume":"12","author":"Yu","year":"2024","journal-title":"Respir Med"},{"key":"10.1016\/j.radonc.2026.111516_b0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2006.07.029","article-title":"Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial","volume":"80","author":"De Ruysscher","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0110","article-title":"Adaptive treatment margins to reduce organs at risk dose in patients with no or minimal anatomical changes in radiotherapy of non-small cell lung cancer","volume":"33","author":"Hattu","year":"2025","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0115","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/acm2.12852","article-title":"Use of surface-guided radiation therapy in combination with IGRT for setup and intrafraction motion monitoring during stereotactic body radiation therapy treatments of the lung and abdomen","volume":"21","author":"Heinzerling","year":"2020","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0120","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0125","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamaoncol.2024.1841","article-title":"Long-term prospective outcomes of intensity modulated radiotherapy for locally advanced lung cancer: a secondary analysis of a randomized clinical trial","volume":"10","author":"Chun","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijrobp.2013.05.040","article-title":"Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer","volume":"87","author":"Shirvani","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acm2.13370","article-title":"Surface guided frameless positioning for lung stereotactic body radiation therapy","volume":"22","author":"Sarudis","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0140","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221112280","article-title":"Correlation of optical surface respiratory motion signal and internal lung and liver tumor motion: a retrospective single-center observational study","volume":"21","author":"Wang","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2026.111516_b0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111516_b0150","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ijrobp.2024.02.063","article-title":"Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small cell lung cancer: a brief report from the CONVERT trial","volume":"119","author":"Walls","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111516_b0155","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1200\/OP-25-00166","article-title":"\u201cTiming is everything\u201d: reflections on twice-daily radiation treatment for small cell lung cancer","volume":"21","author":"Videtic","year":"2025","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.radonc.2026.111516_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2019.08.007","article-title":"EORTC Lung Cancer Group. Current management of limited-stage SCLC and CONVERT trial impact: results of the EORTC Lung Cancer Group survey","volume":"136","author":"Levy","year":"2019","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0165","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35663","article-title":"Quality of life outcomes in patients participating in the CALGB 30610 trial (CALGB 70702): alliance","volume":"131","author":"Ganti","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0170","doi-asserted-by":"crossref","unstructured":"Bi N, Zhang T, Hu X, Zhang L, Zhang J, Cao J, et al. PL03.07 - Hypofractionated vs Conventional Fractionated Radiotherapy With Concurrent Chemotherapy for LS-SCLC: A Multi-Center Phase III Trial. IASLC WCLC 2025, Abstract PL03.07.","DOI":"10.1016\/j.jtho.2025.09.021"},{"key":"10.1016\/j.radonc.2026.111516_b0175","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.37699","article-title":"Comparison of carboplatin with cisplatin in small cell lung cancer in US Veterans","volume":"5","author":"Azar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2026.111516_b0180","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2007.03.002","article-title":"Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Pijls-Johannesma","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2026.111516_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110888","article-title":"Thoracic radiotherapy schedules in limited-stage small cell lung cancer: a systematic review and network meta-analysis","volume":"207","author":"Zhong","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2016.10.003","article-title":"Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer","volume":"102","author":"Halvorsen","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0195","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/annonc\/mdt140","article-title":"Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer","volume":"24","author":"Sun","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0200","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0205","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1200\/JCO.2002.12.071","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104","volume":"20","author":"Takada","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0210","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De Ruysscher","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.lungcan.2021.01.025","article-title":"Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial","volume":"153","author":"Gomes","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0220","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"ADRIATIC Investigators Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111516_b0225","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-25-01569","article-title":"Chemoradiation \u00b1 Atezolizumab in limited-stage small cell lung cancer: results of NRG Oncology\/Alliance LU005","author":"Higgins","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.annonc.2021.09.011","article-title":"ETOP\/IFCT 4-12 STIMULI Collaborators. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy \u2013 results from the randomised phase II ETOP\/IFCT 4-12 STIMULI trial","volume":"33","author":"Peters","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0235","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA8005","article-title":"Randomized phase II trial investigating whether atezolizumab after chemoradiotherapy (CRT) prolongs survival in limited stage (LS) small cell lung cancer (SCLC)","volume":"43","author":"Gr\u00f8nberg","year":"2025","journal-title":"J Clini Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0240","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111516_b0245","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jtho.2018.09.019","article-title":"Prophylactic cranial irradiation for limited-stage small-cell lung cancer patients: secondary findings from the prospective randomized phase 3 CONVERT trial","volume":"14","author":"Levy","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.radonc.2017.07.019","article-title":"Patterns of failure in limited-stage small cell lung cancer: Implications of TNM stage for prophylactic cranial irradiation","volume":"125","author":"Wu","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0255","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S1470-2045(16)30065-1","article-title":"Prophylactic cranial irradiation for patients with lung cancer","volume":"17","author":"P\u00e9choux","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110897","article-title":"The role of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer at different risks of brain metastasis: a multicenter retrospective study","volume":"208","author":"Li","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0265","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(17)30230-9","article-title":"Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Takahashi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107993","article-title":"PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients","volume":"198","author":"Levy","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0275","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"De Dios","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0280","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jtho.2020.12.024","article-title":"Phase 3 randomized trial of prophylactic cranial irradiation with or without hippocampus avoidance in SCLC (NCT01780675)","volume":"16","author":"Belderbos","year":"2021","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0285","unstructured":"Gondi V, Pugh SL, Mehta MP, Wefel JS, Tom\u00e9 WA, Sun AY, et al; NRG Oncology. Hippocampal Avoidance During Prophylactic Cranial Irradiation for Patients With Small Cell Lung Cancer: Randomized Phase II\/III Trial NRG-CC003. J Clin Oncol. 2025 Aug 11:JCO2500221. Epub ahead of print."},{"key":"10.1016\/j.radonc.2026.111516_b0290","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(09)70101-9","volume":"10","author":"Le P\u00e9choux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110314","article-title":"Randomized self-controlled study comparing open-face vs. closed immobilization masks in fractionated cranial radiotherapy","volume":"196","author":"Keane","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0300","doi-asserted-by":"crossref","first-page":"S1267","DOI":"10.1016\/j.annonc.2024.08.2324","article-title":"LBA81 Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial","volume":"35","author":"Senan","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jtho.2018.09.027","article-title":"Compliance and outcome of elderly patients treated in the concurrent once-daily versus twice-daily radiotherapy (CONVERT) trial","volume":"14","author":"Christodoulou","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0310","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.jtho.2023.01.012","article-title":"Treatment outcomes of older participants in a randomized trial comparing two schedules of twice-daily thoracic radiotherapy in limited-stage SCLC","volume":"18","author":"Killingberg","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0315","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.40673","article-title":"Prognostic factors in limited-stage small cell lung cancer: a secondary analysis of CALGB 30610-RTOG 0538","volume":"7","author":"Farris","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2026.111516_b0320","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.radonc.2020.04.001","article-title":"Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement","volume":"146","author":"Guckenberger","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0325","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.lungcan.2021.07.007","article-title":"Stereotactic ablative radiotherapy in T1-2N0M0 small cell lung cancer: a systematic review and meta-analysis","volume":"160","author":"Safavi","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0330","doi-asserted-by":"crossref","first-page":"45 -","DOI":"10.1016\/j.radonc.2019.11.022","article-title":"The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts","volume":"145","author":"Putora","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0335","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.21.01774","article-title":"Indications and parameters around postoperative radiation therapy for lung cancer","volume":"40","author":"Levy","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110123","article-title":"Application of postoperative adjuvant radiotherapy in limited-stage small cell lung cancer: a systematic review and meta-analysis","volume":"193","author":"Zhang","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2025.04.007","article-title":"high-dose versus standard-dose twice-daily thoracic radiotherapy in limited-stage SCLC: final survival data, long-term toxicity, and relapse patterns in a randomized, open-label","author":"Gr\u00f8nberg","year":"2025","journal-title":"Phase II Trial J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0350","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.ijrobp.2024.07.1816","article-title":"Online adaptive radiotherapy for limited-stage small cell lung cancer: a prospective, single-armed, phase II trial","volume":"120","author":"Dong","year":"2024","journal-title":"Int J Radiat Oncol Biol Physics"},{"key":"10.1016\/j.radonc.2026.111516_b0355","article-title":"Assessing dosimetric benefits of cone beam computed tomography-guided online adaptive radiation treatment frequencies for lung cancer","volume":"10","author":"Duan","year":"2025","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111516_b0360","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1002\/cncr.30870","article-title":"Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer","volume":"123","author":"Rwigema","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0365","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","article-title":"Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities","volume":"8","author":"Gay","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2026.111516_b0370","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","article-title":"Challenges of small cell lung cancer heterogeneity and phenotypic plasticity","volume":"25","author":"Simpson","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0375","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/s43018-025-00996-1","article-title":"Advancing therapeutics in small-cell lung cancer","volume":"6","author":"Thomas","year":"2025","journal-title":"Nat Cancer"},{"key":"10.1016\/j.radonc.2026.111516_b0380","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/s43018-025-00992-5","article-title":"The current and emerging immunotherapy paradigm in small-cell lung cancer","volume":"6","author":"Qin","year":"2025","journal-title":"Nat Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026001556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:03:05Z","timestamp":1789750985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026001556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"alternative-id":["S0167814026001556"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111516","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESTRO-EORTC expert guideline on target delineation and radiotherapy details for stage I\u2013III small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111516","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111516"}}